ClinicalTrialsFinder

Non-Small Cell Lung Cancer With EGFR Mutation Clinical Trials in Linhai, Zhejiang

1 recruitingLinhai, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation
Suzhou Genhouse Bio Co., Ltd.94 enrolled6 locationsNCT06306456